Pfizer Says COVID Vaccine for 5- to 11-Year-Olds Is Safe and Shows ‘Robust’ Antibody Response, Experts Say Not So Fast • Children's Health Defense

Experts warn Pfizer’s data is misleading, and some question the need for kids to be vaccinated in the first place.

Pfizer Says COVID Vaccine for 5- to 11-Year-Olds Is Safe and Shows ‘Robust’ Antibody Response, Experts Say Not So Fast

Pfizer plans to request Emergency Use Authorization from the FDA based on data from its phase 2/3 trial for children ages 5 to 11, as experts question the company’s data and need for kids to be vaccinated against COVID.